ML Pharma

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	08-07-2025	23 d early	2025-00245437
31-12-2023	31-07-2024	09-07-2024	22 d early	2024-00230465

Metric	This company	Sector median	Position in the sector
Solvency	17.0%	17.3%	better than 49% of 866 sector peers
Net result	€67k	€14k	better than 70% of 867 sector peers
Equity	€109k	€100k	better than 52% of 868 sector peers
Gross operating margin	€240k	€213k	better than 53% of 794 sector peers
Staff costs	€90k	€219k	higher than 26% of 715 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€643k
Fixed assets	21/28	€317k
Intangible fixed assets	21	€208k
Tangible fixed assets	22/27	€109k
Current assets	29/58	€326k
Stocks & contracts in progress	3	€83k
Amounts receivable within one year	40/41	€104k
Cash & bank	54/58	€135k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€643k
Equity	10/15	€109k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€99k
Amounts payable	17/49	€534k
Amounts payable after one year	17	€200k
Amounts payable within one year	42/48	€332k
Trade debts payable within one year	44	€141k
Income statement
Gross operating margin	9900	€240k
Operating result	9901	€108k
Financial charges	65	€16k
Result before taxes	9903	€92k
Income taxes	67/77	€25k
Net result for the period	9904	€67k
Result to be appropriated	9905	€67k

Summary